1. From the Cardiovascular Division, Department of Pathophysiology, Nagoya University Graduate School of Medicine (H.I., M.Y.), Nagoya; Department of Gene Therapy, Gifu International Institute of Biotechnology (Y.Y., M.T.), Mitake; and the Cardiovascular Center, Nagoya Daini Red Cross Hospital (T.O., H.H.), Nagoya, Japan.